Lightning Round: Clorox, Donaldson, Hanesbrands and More

Clorox : Cramer called the quarter “disappointing” but said he can’t recommend selling the stock at this low level, especially with the 3.5-percent dividend yield.

Meridian Biosciences : Cramer is bullish on diagnostic companies like VIVO and Becton Dickinson.

Donaldson : “Donaldson’s terrific,” Cramer said.

Genpact : Cramer said there is no catalyst coming for Genpact that makes the stock worth recommending.

Micron Technology : Sell MU. “I would much rather have you in any Internet tsunami name that I’ve been recommending,” Cramer said.

Qwest Communications : Cramer likes Qwest’s 4.5-percent dividend yield, as well as the fact that if it merges with CenturyTel investors will get shares of that company. He’s bullish on CTL, which yields 6.7 percent.

Celgene : Cramer thinks the dip in Celgene’s share price, caused by negative news about the company’s Revlimid blood-cancer treatment, is an opportunity to buy the stock. “I think this stock is going to come back,” he said.

Hanesbrands : Go with Warnaco instead, Cramer said.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer

    Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book